Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIHD
UBS AG FI Enhanced Global High Yield ETN
FIHD
|
+$353M |
| 2 |
Televisa
TV
|
+$92.4M |
| 3 |
FLGE
Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes
FLGE
|
+$38.2M |
| 4 |
DST
DST Systems Inc.
DST
|
+$36.8M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIEG
FI Enhanced Global High Yield Exchange Traded Notes
FIEG
|
+$315M |
| 2 |
CAB
Cabela's Inc
CAB
|
+$56.7M |
| 3 |
NXP Semiconductors
NXPI
|
+$48.7M |
| 4 |
TSMC
TSM
|
+$24.7M |
| 5 |
FIGY
Barclays ETN+ FI Enhanced Global High Yield ETN
FIGY
|
+$23.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.9% |
| 2 | Technology | 14.05% |
| 3 | Healthcare | 12.4% |
| 4 | Consumer Discretionary | 7.69% |
| 5 | Industrials | 6.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLDT
501
Chatham Lodging
CLDT
$622M
| $475K | ﹤0.01% |
23,129
-15,845
| -41% | -$304K |
|
502
Occidental Petroleum
OXY
$56.8B
| $466K | ﹤0.01% |
6,537
+148
| +2% | +$10.5K |
|
|
HT
503
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $466K | ﹤0.01% |
21,656
-14,208
| -40% | -$277K |
|
|
EGRX
504
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $459K | ﹤0.01% |
5,780
-3,770
| -39% | -$274K |
|
505
United Therapeutics
UTHR
$25.8B
| $448K | ﹤0.01% |
3,124
| – | – |
|
506
Northrop Grumman
NOC
$77.1B
| $446K | ﹤0.01% |
1,918
+48
| +3% | +$11.2K |
|
|
PRAH
507
DELISTED
PRA Health Sciences, Inc.
PRAH
| $445K | ﹤0.01% |
+8,075
| New | +$443K |
|
508
CubeSmart
CUBE
$9.39B
| $439K | ﹤0.01% |
+16,400
| New | +$420K |
|
|
GLUU
509
DELISTED
Glu Mobile Inc.
GLUU
| $439K | ﹤0.01% |
226,417
-72,900
| -24% | -$153K |
|
510
Medtronic
MDT
$109B
| $434K | ﹤0.01% |
6,096
+1,147
| +23% | +$90.1K |
|
511
Marathon Petroleum
MPC
$92.4B
| $428K | ﹤0.01% |
8,500
-206
| -2% | -$9.35K |
|
512
iShares MSCI South Korea ETF
EWY
$21.9B
| $423K | ﹤0.01% |
7,949
-2,422
| -23% | -$132K |
|
|
BNY
513
Bank of New York Mellon
BNY
$106B
| $411K | ﹤0.01% |
8,676
-1,039
| -11% | -$46.9K |
|
|
XEC
514
DELISTED
CIMAREX ENERGY CO
XEC
| $408K | ﹤0.01% |
3,000
| – | – |
|
515
Duke Energy
DUK
$97.8B
| $404K | ﹤0.01% |
5,200
+2,351
| +83% | +$180K |
|
516
DHT Holdings
DHT
$2.99B
| $403K | ﹤0.01% |
97,246
-42,786
| -31% | -$170K |
|
517
Danaher
DHR
$137B
| $399K | ﹤0.01% |
5,783
-714
| -11% | -$49.6K |
|
|
APC
518
DELISTED
Anadarko Petroleum
APC
| $399K | ﹤0.01% |
5,717
-325
| -5% | -$21.1K |
|
519
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.89B
| $398K | ﹤0.01% |
14,378
-288
| -2% | -$7.93K |
|
520
Ametek
AME
$55.4B
| $393K | ﹤0.01% |
+8,077
| New | +$383K |
|
521
Mercado Libre
MELI
$95.2B
| $393K | ﹤0.01% |
2,517
| – | – |
|
522
Southern Company
SO
$109B
| $392K | ﹤0.01% |
7,975
-1,657
| -17% | -$81.4K |
|
523
Vertex Pharmaceuticals
VRTX
$121B
| $381K | ﹤0.01% |
5,168
| – | – |
|
|
CNCE
524
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $372K | ﹤0.01% |
36,163
| – | – |
|
525
Illinois Tool Works
ITW
$82.6B
| $370K | ﹤0.01% |
3,024
+287
| +10% | +$34.7K |
|
Similar funds
Ken Fisher's Q4 2016 Portfolio in Review
As of Q4 2016, Ken Fisher held 837 positions worth $57.4B, up 2% from $56.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Ken Fisher's Q4 2016 filing shows 61 new, 208 increased, 401 reduced and 54 closed positions. Its largest new stake was Barclays ETN+ FI Enhanced Europe 50 ETN Series B: 174,286 shares worth $18.7M. The largest sale was FI Enhanced Global High Yield Exchange Traded Notes, an estimated $315M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- Ken Fisher's largest Q4 2016 buy was Barclays ETN+ FI Enhanced Europe 50 ETN Series B: 174,286 shares worth $18.7M.
- Ken Fisher added most to UBS AG FI Enhanced Global High Yield ETN in Q4 2016, an estimated $353M increase.
- Ken Fisher's biggest Q4 2016 reduction was FI Enhanced Global High Yield Exchange Traded Notes, cutting an estimated $315M.
- Ken Fisher fully exited Cabela's Inc in Q4 2016, selling an estimated $56.7M.
- Ken Fisher's ten largest holdings make up 22% of its $57.4B portfolio in Q4 2016.
- Ken Fisher opened 61 new positions and closed 54 in Q4 2016.
- Ken Fisher's portfolio value rose 2% quarter-over-quarter to $57.4B.
Based on Fisher Asset Management's 13F filing for Q4 2016, filed 10 Jan 2017.